Washington, DC
September 30, 2008
Syngenta announced a multi-year agreement with
Metabolon for biochemical
profiling technology that will enhance the Syngenta technical
toolkit for its seeds research programs. This agreement will
support Syngenta researchers' understanding of plants' response
to environmental conditions and decisions on crop traits earlier
in the development cycle.
"Biochemical profiling is becoming an important part of
Syngenta's focused program to apply the full range of
cutting-edge science to supply solutions for growers," said
Roger Kemble, Ph.D., Head, Syngenta Crop Genetics Research.
"Metabolon's technology will enable Syngenta's insights to the
performance of our products as we focus in bringing the next
generations of seed science across native traits and GM paths to
unlock crop productivity."
"We are excited to expand our partnership with Syngenta, a
leading seed biotechnology company," said John Ryals, Ph.D.,
president and chief executive of Metabolon. "This agreement
brings Syngenta into our growing stable of commercial partners
in the pharmaceutical, biotechnology and consumer product
sectors and we look forward to providing further actionable
insight with our global biochemical analysis."
This agreement expands upon initial studies performed by
Metabolon for Syngenta to test the application of the
technology. Financial terms of the agreement were not disclosed.
Syngenta is a world-leading agribusiness committed to
sustainable agriculture through innovative research and
technology. The company is a leader in crop protection, and
ranks third in the high-value commercial seeds market. Sales in
2007 were approximately $9.2 billion. Syngenta employs over
21,000 people in more than 90 countries. Syngenta is listed on
the Swiss stock exchange (SYNN) and in New York (SYT). |
|
